Success Stories: Our Competent Team Supported a Plant Scientist to Achieve NIW Approval in the Field of Plant Sciences in Just 5 Days, No RFE Issued

Client’s Testimonial:

“Wow, that was quick. Thank you for all your help.”

On February 27^th, 2024, we received another EB-2 NIW (National Interest Waiver) approval for a Plant Scientist in the Field of Plant Sciences (Approval Notice).

General Field: Plant Sciences

Position at the Time of Case Filing: Plant Scientist

Country of Origin: India

Approval Notice Date: February 27^th, 2024

Processing Time: 5 days (Premium Processing Requested)

Case Summary:

In August 2023, a Plant Scientist from India approached us about filing an NIW (National Interest Waiver) petition on her behalf. Because NIW applicants and beneficiaries must have an “advanced degree” or “exceptional ability” in the sciences, we were able to confirm that our client is an expert in the field of plant sciences because she has a Ph.D. in horticultural sciences and has convincingly demonstrated that she seeks employment in an area of significant intrinsic merit to the United States that will be national in scope.

We also discovered that she intends to pursue her research on elucidating the genetic mechanisms underlying complex plant traits and applying integrated traditional and modern plant breeding techniques with high yield, disease resistance, and enhanced nutritional quality in order to address and remedy global food and feed needs. Thus, her research seemed relevant to the enhancement of superior crop yield and production whilst mitigating food insecurity and climate change.

After carefully reviewing our client’s qualifications, we decided to countersign the client-attorney agreement. We aimed at accentuating the great importance of her research which directly addresses the urgent global challenge of enhancing food security and nutritional quality. We incorporated the following details in our customized petition package:

It was noteworthy for us to mention the significance of her research work, which has also been granted funding by the Indian Department of Science and Technology. This funding support evidently addresses contemporary challenges and advances the development of key solutions in science and technology, particularly for addressing food insecurity.
Due to her great knowledge in the field of plant sciences, she has been regularly invited to conduct peer reviews for honored, and she has conducted at least 14 peer reviews to date.
Besides, her research has resulted in 6 peer-reviewed journal articles (2 of them first-authored) and 1 book chapter, and these papers have been published in no fewer than 2 highly ranked peer-reviewed journals.
She not only completed and published the results of her field research, but her findings also influenced her colleagues. Thus, her work has been cited 30 times, indicating that her discoveries were well received by the field, and her efforts have encouraged new research in numerous fields of plant sciences.

The submitted NIW petition package highlights the significance of our client’s work in crop variety enhancement for increased sustainability. Her research, which reduces the need for chemical inputs in agriculture through the introduction of robust crop types, benefits the health of these ecosystems while fulfilling rising food demand. Therefore, we are grateful to our client for choosing the North America Immigration Law Group to successfully represent her in her EB-2 NIW application before the USCIS, resulting in approval only 5 days after filing the case. We wish her success as she advances in her field of specialization.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 47,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our approved cases grew from 600 in 2013 to over 47,000 in 2023.